NCT03662282View on ClinicalTrials.gov

Omegaven as Alternative Parenteral Fat Nutrition

PHASE3CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

October 23, 2018

Primary Completion Date

January 7, 2019

Study Completion Date

January 7, 2019

Conditions
CholestasisCholestasis of Parenteral Nutrition
Interventions
DRUG

Omegaven

Omegaven® fat emulsion will be used as a compassionate use treatment for critically ill infants with parenteral nutrition associated liver injury

Trial Locations (1)

33606

USF Health, Tampa

All Listed Sponsors
lead

University of South Florida

OTHER

NCT03662282 - Omegaven as Alternative Parenteral Fat Nutrition | Biotech Hunter | Biotech Hunter